Spots Global Cancer Trial Database for Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
Official Title: Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
Study ID: NCT03436485
Conditions
Study Description
Brief Summary: The purpose of this first-in-man study is to evaluate safety and tolerability of ODM-208 in patients with metastatic castration-resistant prostate cancer.
Detailed Description: Safety and tolerability profile of ODM-208 will be explored
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland, United States
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Nebraska Cancer Specialists, Omaha, Nebraska, United States
University at Buffalo, Kaleida Health Great Lakes Cancer Care Collaborative, Buffalo, New York, United States
Helsinki University Central Hospital, Helsinki, , Finland
Tampere University Hospital, Tampere, , Finland
Institute Bergonié, Bordeaux, , France
Centre Léon Bérard, Lyon, , France
Institute Paoli-Calmettes, Marseille, , France
Institut de cancérologie Strasbourg Europe, Strasbourg, , France
Hopital Foch, Suresnes, , France
Institut Gustave Roussy, Villejuif, , France
The Rutherford Cancer Centre, North East, Bedlington, , United Kingdom
Velindre Cancer Centre, Cardiff, , United Kingdom
The Beatson West of Scotland Cancer Centre, Glasgow, , United Kingdom
The Rutherford Cancer Centre, North West, Liverpool, , United Kingdom
Royal Marsden Hospital, London, , United Kingdom
Charing Cross Hospital, London, , United Kingdom
The Christie NHS Foundation Trust, Manchester, , United Kingdom
Royal Preston Hospital, Preston, , United Kingdom
Contact Details
Name: Karim Fizazi
Affiliation: Gustave Roussy, Cancer Campus, Grand Paris
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
